Skip to content
SEC filings edition: Friday, November 13, 2026 · 767 companies with filings Publisher's serviceBoardeon, your AI board · Hire your board →
Monday, November 16, 2026Every business day from SEC EDGAR
SEC EDGAR · Nov 13, 2026 1bankruptcies 11delisting notices 12late filings 43leadership changes 6IPO filings 199private raises 90earnings releases
Company page · CIK 1583107

Theravance Biopharma, Inc.

Deregistered (Form 15) SEC-reporting company George Town, Grand Cayman, CA
An email when it files something new with the SEC. Your account

What this means

  • Exchange listing at riskOn Sep 23, 2026 the company disclosed a notice from its exchange (Item 3.01). Exchanges usually give a period to regain compliance before delisting.
  • Securities removed from an exchangeA Form 25-NSE filed on Sep 23, 2026 removes a class of the company’s securities from listing. It can concern shares, warrants, notes or units — check the form for the class.
  • Stopped reporting to the SECThe company filed Form 15-12G on Oct 5, 2026 to terminate or suspend its SEC reporting. After that it no longer files annual and quarterly reports, so less public information is available.
  • RestructuringOn Mar 3, 2026 the company committed to an exit or disposal plan with material costs (Item 2.05).
  • Change in controlOn Sep 23, 2026 the company reported a change in control (Item 5.01).

What to do next

Guides from the Companies Daily newsroom, picked for what the register shows.

Financials from XBRL

Calendar-year frame20252024
Revenue$107M$64.4M
Net income (loss)$106M−$56.4M
Total assets$486M$354M
Stockholders’ equity$297M$176M
Cash and equivalents$168M$37.8M

From XBRL data the company filed with the SEC (data.sec.gov frames, US GAAP, US dollars). A frame aligns the fiscal year with the calendar year closest to it; this company’s fiscal year ends December 31. Check the annual report for the exact figures and periods.

Name as filed
Theravance Biopharma, Inc.
CIK
0001583107
Tickers
—
Kind of filer
SEC-reporting company
Non-accelerated filer; Smaller reporting company
Status
Deregistered (Form 15)
State of incorporation
California
Business address
George Town, Grand Cayman, California
Industry (SIC)
2834 · Pharmaceutical preparations
Industry: D · Manufacturing →
Fiscal year ends
December 31
Last annual report
10-K for the period ended Dec 31, 2025
Last quarterly report
10-Q for the quarter ended Jun 30, 2026
Bankruptcy reported
Not in our data
Last edition event
Oct 5, 2026

Filing history

Newest first: the filings we classify (8-K items, late filing notices, delistings, deregistration, IPO registrations, Schedule 13D, Form D, annual and quarterly reports), from Jan 1, 2023. All documents, including those we do not classify, are in the EDGAR filing index.

  • Deregistered from SEC reporting: Form 15-12G: termination of registration
    Form 15-12G · filed Oct 5, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 1.01, 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 8.01, 9.01 · filed Sep 23, 2026 · filing
  • Change in control
    Form 8-K · items 1.01, 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 8.01, 9.01 · filed Sep 23, 2026 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 1.01, 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 8.01, 9.01 · filed Sep 23, 2026 · filing
  • Acquisition or disposal completed
    Form 8-K · items 1.01, 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 8.01, 9.01 · filed Sep 23, 2026 · filing
  • Delisted by the exchange (Form 25-NSE)
    Form 25-NSE · filed Sep 23, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2026
    Form 10-Q · filed Aug 11, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Aug 10, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Jun 23, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed May 7, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2026
    Form 10-Q · filed May 7, 2026 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2025
    Form 10-K · filed Mar 23, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Mar 19, 2026 · filing
  • Restructuring or layoffs
    Form 8-K · items 2.02, 2.05, 7.01, 9.01 · filed Mar 3, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 2.05, 7.01, 9.01 · filed Mar 3, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2025
    Form 10-Q · filed Nov 12, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Nov 10, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2025
    Form 10-Q · filed Aug 13, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Aug 12, 2025 · filing
  • Acquisition or disposal completed
    Form 8-K · items 1.01, 2.01, 7.01, 9.01 · filed Jun 2, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2025
    Form 10-Q · filed May 12, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed May 8, 2025 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2024
    Form 10-K · filed Mar 7, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Feb 26, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2024
    Form 10-Q · filed Nov 14, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Nov 12, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2024
    Form 10-Q · filed Aug 8, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Aug 5, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2024
    Form 10-Q · filed May 15, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed May 13, 2024 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2023
    Form 10-K · filed Mar 1, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Feb 26, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 1.01, 5.02, 7.01, 9.01 · filed Dec 21, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2023
    Form 10-Q · filed Nov 9, 2023 · filing
  • Directors or officers changed
    Form 8-K · items 2.02, 5.02, 9.01 · filed Nov 7, 2023 · filing
  • Results announced
    Form 8-K · items 2.02, 5.02, 9.01 · filed Nov 7, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2023
    Form 10-Q · filed Aug 9, 2023 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Aug 7, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2023
    Form 10-Q · filed May 10, 2023 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed May 8, 2023 · filing
  • Directors or officers changed
    Form 8-K · items 3.03, 5.02, 5.03, 5.07, 9.01 · filed May 3, 2023 · filing
  • Stake of 5% or more with intent to influence: Schedule 13D: stake of 5% or more
    Form SC 13D · filed Apr 12, 2023 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 8.01 · filed Apr 11, 2023 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2022
    Form 10-K · filed Mar 1, 2023 · filing
  • Directors or officers changed
    Form 8-K · items 2.02, 5.02, 9.01 · filed Feb 27, 2023 · filing
  • Results announced
    Form 8-K · items 2.02, 5.02, 9.01 · filed Feb 27, 2023 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Jan 9, 2023 · filing